PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations

MLA

Tiantian Ma, et al. “PD-L1 Expression, Tumor Mutational Burden, and Immune Cell Infiltration in Non-Small Cell Lung Cancer Patients with Epithelial Growth Factor Receptor Mutations.” Frontiers in Oncology, vol. 12, Aug. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.922899.

APA

Tiantian Ma, Jin Jiao, Ran Huo, Xiaofang Li, Guotao Fang, Qi Zhao, Weiwei Liu, Xiao Han, Chenglin Xi, Yanan Wang, & Yanhong Shang. (2022). PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.922899

Chicago

Tiantian Ma, Jin Jiao, Ran Huo, Xiaofang Li, Guotao Fang, Qi Zhao, Weiwei Liu, et al. 2022. “PD-L1 Expression, Tumor Mutational Burden, and Immune Cell Infiltration in Non-Small Cell Lung Cancer Patients with Epithelial Growth Factor Receptor Mutations.” Frontiers in Oncology 12 (August). doi:10.3389/fonc.2022.922899.